European stocks plunge, dragging down US stocks; S&P 500 falls 0.22%
智通财经2026/10/08 07:36Deutsche Bank strategists stated: “A widening bond spread and renewed inflation concerns led to a tough day for risk assets.” The impact was especially apparent in European markets, with the STOXX 600 Index falling by 1.00%, ending a three-day winning streak. France’s CAC 40 Index dropped 1.22%, Italy’s FTSE MIB Index lost 2.51%, and European banking stocks declined by 3.38%, making them the worst-performing sector. “This weakness also extended to the US market, where the S&P 500 Index fell 0.22%, pulling back from the record high reached the previous day. Although the index pared some losses throughout the session, internal pressures remained apparent, with nearly three-quarters of its constituents declining. Industrials and materials retreated by 2.14% and 1.53% respectively, with cyclical sectors especially weak. Technology stocks demonstrated some resilience, limiting the declines in the Nasdaq Index and the ‘Magnificent Seven’ to 0.22% and 0.20% respectively. However, the small-cap Russell 2000 Index dropped by 1.31%, hitting a four-month low.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China
According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Abu Dhabi National Oil Company invites bids for crude oil cargo shipments
Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.
The Central Bank of Turkey conducts a 6-ton gold-for-lira weekly sell swap auction.
The Central Bank of Turkey conducted a one-week gold-for-lira sell swap auction using traditional methods, with a scale of 6 tons.

European Court of Auditors: EU debt continues to rise and may reach 1 trillion euros by 2027
On October 8 local time, the European Court of Auditors (ECA) released its 2025 annual report, expressing concerns over the continuous growth of EU debt. According to the report, by the end of 2025, the EU's debt had reached approximately 740 billion euros. The report also warns that this figure may further rise to 1 trillion euros by 2027. The ECA pointed out that the increase in EU debt is mainly related to aid for Ukraine, rising interest rates, defense spending, and the EU recovery fund. (CCTV)